Rafferty Asset Management
BOLD

Rafferty Asset Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Rafferty Asset Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-21,684
Closed -$1.3M – 892
2019
Q4 		$1.3M Sell
21,684
-60,310
-74% -$2.26M 0.02% 488
2019
Q3 		$2.3M Sell
81,994
-4,092
-5% -$140K 0.04% 311
2019
Q2 		$3.26M Buy
86,086
+36,110
+72% +$1.39M 0.06% 243
2019
Q1 		$1.95M Buy
+49,976
New +$1.43M 0.03% 407

Rafferty Asset Management's BOLD Position: Q1 2020 in Review

Rafferty Asset Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 21,684 shares — an estimated $1.3M sold.

Rafferty Asset Management first reported a position in BOLD in Q1 2019 and held it in 4 quarters. The position peaked at $3.26M in Q2 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Rafferty Asset Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Rafferty Asset Management sold 21,684 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $1.3M.
  • Rafferty Asset Management first reported a position in Audentes Therapeutics, Inc in Q1 2019 and held it in 4 quarters.
  • Rafferty Asset Management's Audentes Therapeutics, Inc position peaked at $3.26M in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Rafferty Asset Management's 13F filing for Q1 2020, filed 15 May 2020.